230 related articles for article (PubMed ID: 34368075)
1. Cellular Basis of Organotin(IV) Derivatives as Anticancer Metallodrugs: A Review.
Syed Annuar SN; Kamaludin NF; Awang N; Chan KM
Front Chem; 2021; 9():657599. PubMed ID: 34368075
[TBL] [Abstract][Full Text] [Related]
2. Series of Organotin(IV) Compounds with Different Dithiocarbamate Ligands Induced Cytotoxicity, Apoptosis and Cell Cycle Arrest on Jurkat E6.1, T Acute Lymphoblastic Leukemia Cells.
Rasli NR; Hamid A; Awang N; Kamaludin NF
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110610
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic Activity of Organotin(IV) Derivatives with Triazolopyrimidine Containing Exocyclic Oxygen Atoms.
Attanzio A; D'Agostino S; Busà R; Frazzitta A; Rubino S; Girasolo MA; Sabatino P; Tesoriere L
Molecules; 2020 Feb; 25(4):. PubMed ID: 32075253
[TBL] [Abstract][Full Text] [Related]
4. Organotin (IV) Dithiocarbamate Compounds as Anticancer Agents: A Review of Syntheses and Cytotoxicity Studies.
Abd Aziz NA; Awang N; Chan KM; Kamaludin NF; Mohamad Anuar NN
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570810
[TBL] [Abstract][Full Text] [Related]
5. Anti-proliferative and antitumor activity of organotin(IV) compounds. An overview of the last decade and future perspectives.
Banti CN; Hadjikakou SK; Sismanoglu T; Hadjiliadis N
J Inorg Biochem; 2019 May; 194():114-152. PubMed ID: 30851663
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of new Organotin(IV) anticancer agents and their cytotoxicity profile on HL-60, MCF-7 and HeLa human cancer cell lines.
Ullah H; Previtali V; Mihigo HB; Twamley B; Rauf MK; Javed F; Waseem A; Baker RJ; Rozas I
Eur J Med Chem; 2019 Nov; 181():111544. PubMed ID: 31374420
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Ultraviolet Irradiation on the Physicochemical Properties of Poly(vinyl Chloride) Films Containing Organotin(IV) Complexes as Photostabilizers.
Ghazi D; El-Hiti GA; Yousif E; Ahmed DS; Alotaibi MH
Molecules; 2018 Jan; 23(2):. PubMed ID: 29382088
[TBL] [Abstract][Full Text] [Related]
8.
Yusof ENM; Latif MAM; Tahir MIM; Sakoff JA; Simone MI; Page AJ; Veerakumarasivam A; Tiekink ERT; Ravoof TBSA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781445
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Evaluation of Antiproliferative Properties of Novel Organotin(IV) Carboxylate Compounds with Propanoic Acid Derivatives on a Panel of Human Cancer Cell Lines.
Pantelić NĐ; Božić B; Zmejkovski BB; Banjac NR; Dojčinović B; Wessjohann LA; Kaluđerović GN
Molecules; 2021 May; 26(11):. PubMed ID: 34071809
[TBL] [Abstract][Full Text] [Related]
10. Potentially bioactive organotin(IV) compounds: synthesis, characterization, in vitro bioactivities and interaction with SS-DNA.
Sirajuddin M; Ali S; McKee V; Sohail M; Pasha H
Eur J Med Chem; 2014 Sep; 84():343-63. PubMed ID: 25036793
[TBL] [Abstract][Full Text] [Related]
11. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
12. Organotin(IV) Dithiocarbamate Complexes: Chemistry and Biological Activity.
Adeyemi JO; Onwudiwe DC
Molecules; 2018 Oct; 23(10):. PubMed ID: 30304779
[TBL] [Abstract][Full Text] [Related]
13. Photostabilization of Poly(vinyl chloride) by Organotin(IV) Compounds against Photodegradation.
Hadi AG; Jawad K; El-Hiti GA; Alotaibi MH; Ahmed AA; Ahmed DS; Yousif E
Molecules; 2019 Oct; 24(19):. PubMed ID: 31581427
[TBL] [Abstract][Full Text] [Related]
14. Recent Advancements in Organotin(IV) Complexes as Potent Cytotoxic Agents.
Devi J; Boora A; Rani M; Arora T
Anticancer Agents Med Chem; 2023; 23(2):164-191. PubMed ID: 35619310
[TBL] [Abstract][Full Text] [Related]
15. Tin(IV) cyanoximates: synthesis, characterization, and cytotoxicity.
Gerasimchuk N; Maher T; Durham P; Domasevitch KV; Wilking J; Mokhir A
Inorg Chem; 2007 Sep; 46(18):7268-84. PubMed ID: 17676728
[TBL] [Abstract][Full Text] [Related]
16. Recent Advancements in Organotin(IV) Complexes as Potential Anticancer Agents.
Devi J; Yadav J
Anticancer Agents Med Chem; 2018; 18(3):335-353. PubMed ID: 29110624
[TBL] [Abstract][Full Text] [Related]
17. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
Sirajuddin M; McKee V; Tariq M; Ali S
Eur J Med Chem; 2018 Jan; 143():1903-1918. PubMed ID: 29133050
[TBL] [Abstract][Full Text] [Related]
18. Biological Evaluation of Triorganotin Derivatives as Potential Anticancer Agents.
Stefanizzi V; Minutolo A; Valletta E; Carlini M; Cordero FM; Ranzenigo A; Prete SP; Cicero DO; Pitti E; Petrella G; Matteucci C; Marino-Merlo F; Mastino A; Macchi B
Molecules; 2023 May; 28(9):. PubMed ID: 37175265
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and discovery of multiple anticancer mechanisms of dibutyltin complexes based on salen-like ligands.
Tian W; Zhong W; Yang Z; Chen L; Lin S; Li Y; Wang Y; Yang P; Long X
J Inorg Biochem; 2024 Feb; 251():112434. PubMed ID: 38029537
[TBL] [Abstract][Full Text] [Related]
20. Organotin(IV) Carboxylates as Promising Potential Drug Candidates in the Field of Cancer Chemotherapy.
Sirajuddin M; Ali S
Curr Pharm Des; 2016; 22(44):6665-6681. PubMed ID: 27604610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
